You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMN

Showing 1 - 25 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting
  • AMN
  • +2 more
  • SBT101
  • Imitation Procedure
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Jun 1, 2022

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) Trial in United States (VK0214, Placebo)

Recruiting
  • Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)
  • Palo Alto, California
  • +3 more
Jul 19, 2022

ALD (Adrenoleukodystrophy) Trial (PXL065)

Not yet recruiting
  • ALD (Adrenoleukodystrophy)
  • (no location specified)
Feb 23, 2022

Adrenomyeloneuropathy Trial (PXL770)

Not yet recruiting
  • Adrenomyeloneuropathy
  • (no location specified)
Feb 23, 2022

Adrenomyeloneuropathy, Adrenoleukodystrophy Trial in L'Hospitalet de Llobregat (Albumin solution)

Completed
  • Adrenomyeloneuropathy
  • Adrenoleukodystrophy
  • Albumin solution
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Bellvitge University Hospital
Sep 21, 2022

Chronic Myeloid Leukemia Trial in New York (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Mar 24, 2022

Chordoma Trial in Boston (Nilotinib, Radiation therapy)

Active, not recruiting
  • Chordoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 27, 2021

Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
Feb 14, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Non-invasive Risk Stratification of CR AMN/SSP

Recruiting
  • Adenomatous Polyps
  • blood or stool samples will be collected
  • Westmead, New South Wales, Australia
    Westmead Endoscopy Unit
Mar 21, 2021

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed
  • Glomerulonephritis, Membranous
  • antiPLA2R Positive
  • Azusa, California
  • +44 more
Dec 12, 2022

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Multiple Myeloma Trial (Vorinostat, bortezomib, to vorinostat)

Completed
Has Results
  • Multiple Myeloma
  • (no location specified)
Apr 29, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Adrenoleukodystrophy Trial in Worldwide (MIN-102, Placebos)

Active, not recruiting
  • Adrenoleukodystrophy
  • Stanford, California
  • +9 more
Oct 29, 2021

Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

Active, not recruiting
  • Glomerulonephritis
  • +2 more
  • Tbilisi, Georgia
  • +24 more
Aug 23, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 19, 2021

Chronic GVHD Trial in Israel, Italy (nilotinib)

Completed
  • Chronic Graft Versus Host Disease
  • Tel Hashomer, Israel
  • +11 more
Aug 19, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

GIST and CML Trial in Worldwide (AMN107)

Active, not recruiting
  • GIST and CML
  • Albany, New York
  • +32 more
Oct 4, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Chronic Myeloid Leukemia Trial in Germany, United Kingdom (Tasigna)

Completed
  • Chronic Myeloid Leukemia
  • Frankfurt/M, Germany
  • +4 more
Dec 6, 2020